Effects of a New Calcium Channel Blocker, Azelnidipine, on Systemic Hemodynamics and Renal Sympathetic Nerve Activity in Spontaneously Hypertensive Rats
Authors:
- 1 January 2005
- journal article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 28 (12) , 1017-1023
Abstract
Antihypertensive treatment with dihydropyridine calcium channel blockers elicits sympathetic nerve activation, which may contribute to cardiovascular events. However, recent clinical studies showed that treatment with azelnidipine, a new dihydropyridine calcium channel blocker, significantly reduced blood pressure in hypertensive patients while either maintaining or actually decreasing heart rate (HR). In this study, we examined the effects of azelnidipine and amlodipine on systemic hemodynamics and renal sympathetic nerve activity (RSNA) in anesthetized spontaneously hypertensive rats (SHR). We also examined the effects of these agents on baroreflex functions by infusing phenylephrine (30 μg/kg/min, i.v.) and sodium nitroprusside (10 μg/kg/min, i.v.) into azelnidipine- or amlodipine-treated SHR. Fifty min after administration of azelnidipine (10 μg/kg/min for 10 min, i.v.), mean arterial pressure (MAP) significantly decreased from 153±5 to 122±5 mmHg; however, HR and integrated RSNA did not change significantly (from 352±9 to 353±10 beats/min and 115±5% of baseline, respectively). Infusion of amlodipine (50 μg/kg/min for 10 min) elicited similar effects on MAP (from 152±5 to 120±4 mmHg). However, amlodipine significantly increased HR (from 351±9 to 375±11 beats/min) and integrated RSNA (165±5% of baseline). Analyses of baroreflex function curves revealed that azelnidipine-treated rats showed a smaller baroreflex function than amlodipine-treated rats (p<0.05). These data suggest that azelnidipine possesses sympathoinhibitory effects, which may be one reason why it had less pronounced effects on HR in hypertensive patients.Keywords
This publication has 26 references indexed in Scilit:
- Renoprotective Effect of Losartan in Comparison to Amlodipine in Patients with Chronic Kidney Disease and Hypertension-a Report of the Japanese Losartan Therapy Intended for the Global Renal Protection Hypertensive Patients (JLIGHT) StudyHypertension Research, 2004
- Comparison of Nifedipine Retard with Angiotensin Converting Enzyme Inhibitors in Japanese Hypertensive Patients with Coronary Artery Disease: The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) Randomized TrialHypertension Research, 2004
- Guidelines for Treatment of Hypertension in the Elderly. 2002 Revised Version.Hypertension Research, 2003
- Effects of Chronic Calcium Channel Blockade on Sympathetic Nerve Activity in HypertensionHypertension, 2002
- Differential Effects of a Long-Acting Angiotensin Converting Enzyme Inhibitor (Temocapril) and a Long-Acting Calcium Antagonist (Amlodipine) on Ventricular Ectopic Beats in Older Hypertensive Patients.Hypertension Research, 2002
- Central sympathoinhibitory effects of calcium channel blockersCurrent Hypertension Reports, 2001
- Effects of Amlodipine on Sympathetic Nerve Traffic and Baroreflex Control of Circulation in Heart FailureHypertension, 1999
- Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipineJournal Of Hypertension, 1998
- NifedipineCirculation, 1995
- The risk of myocardial infarction associated with antihypertensive drug therapies1995